Genetic Technologies Limited
GNTLF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $14,540 | $22,821 | $33,387 | $34,166 |
| - Cash | $1,021 | $7,851 | $11,731 | $20,902 |
| + Debt | $875 | $533 | $653 | $204 |
| Enterprise Value | $14,394 | $15,503 | $22,308 | $13,467 |
| Revenue | $9,673 | $10,348 | $9,218 | $1,335 |
| % Growth | -6.5% | 12.3% | 590.6% | – |
| Gross Profit | $3,904 | $6,013 | $6,474 | -$240 |
| % Margin | 40.4% | 58.1% | 70.2% | -18% |
| EBITDA | -$11,431 | -$11,203 | -$7,201 | -$7,156 |
| % Margin | -118.2% | -108.3% | -78.1% | -536.1% |
| Net Income | -$12,017 | -$11,751 | -$7,131 | -$7,078 |
| % Margin | -124.2% | -113.6% | -77.4% | -530.3% |
| EPS Diluted | -0.091 | -0.12 | -0.077 | -0.083 |
| % Growth | 24.3% | -55.2% | 6.6% | – |
| Operating Cash Flow | -$9,679 | -$9,723 | -$5,659 | -$6,296 |
| Capital Expenditures | -$33 | -$18 | -$97 | -$642 |
| Free Cash Flow | -$9,712 | -$9,741 | -$5,756 | -$6,938 |